Red cell membrane protein analysis by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and direct quantitation by radioimmunoassay or cytofluorometry defines four distinct subsets of patients with hereditary spherocytosis: Patients with isolated spectrin deficiency, combined spectrin and ankyrin deficiency, band 3 deficiency, and protein 4.2 deficiency. In regard to the first group, only one mutation of p spectrin has been reported in the literature. We describe a spectrin variant characterized by a truncated p chain, and associated with hereditary spherocytosis and isolated spectrin deficiency. The clinical phenotype consists of a moderate hemolytic anemia with spherocytosis and frequent spiculation of the red cells. We present the biochemical characteristics of this mutant protein and show that it constitutes only 12% of the total spectrin on the membrane. We show that the truncation of the protein is the
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2538 result of a single point mutation at position + l (G + A) of the donor consensus splice site of intron 17 leading t o an aberrant p speetrin transcriptional message lacking exons 16 and 17. To elucidate the basis for the decreased amount of the truncated protein on the membrane and the overall spectrin deficiency, we provide evidence that the mutated gene is transcribed but its mRNA is less abundant than its normal counterpart in reticulocytes; we also show that the mutant protein is synthesized in decreased amounts in the cytoplasm of erythroid progenitor cells, and appears to be susceptible t o proteolytic degradation. This mutant spectrin underscores the importance of the regulatory role played by the fi spectrin molecule in the assembly of afi spectrin heterodimers on the membrane. 0 1996 by The American Society of Hematology.
The skeleton is attached to the membrane mainly by ankyrin, which links spectrin to the transmembrane protein, band 3. The ankyrin binding domain of spectrin has been mapped to the 15th repeated segment of the 0 spectrin subunit."
In patients with HS, the biochemical analysis of the red cell membrane proteins by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), or by direct quantitation using radioimmunoassay or fluorocytometry has identified four distinct abnormalities corresponding to four different subsets of patients: (1) isolated spectrin deficiency,l,2,'2 (2) combined spectrin and ankyrin deficiency,"." (3) band 3 deficiency,'"'' and (4) defects of protein 4.2.2""1 The correlation between the biochemical defects and the severity of the hemolysis remains poorly defined.
At the molecular level, point mutations and deletions involving the genes of band 3, ankyrin, protein 4.2 and spectrin are being uncovered, further defining the four subsets of patients described above. Point mutations and small deletions involving the band 3 gene have been described in patients with HS and band 3 deficien~y.~',~~ Likewise point mutations of the ankyrin gene25,26 and the protein 4.2 gene have been disclosed in the subsets of patients with ankyrin deficiency and protein 4.2 deficiency, respectively. In the patients with isolated spectrin deficiency, no mutations of a spectrin have been reported so far. This is most likely due to the fact that a spectrin is synthesized in approximately threefold excess of 0 ~pectrin~'.*~ with the redundant, unassembled a chains undergoing degradation in the lysosomal compartment." Consequently, the 0 spectrin synthesis appears to be the rate limiting factor for the assembly of spectrin ap heterodimers on the membrane. Therefore, in contrast to a spectrin, defects of 0 spectrin are more likely to be expressed in the heterozygous state. A point mutation occurring in the N-terminal region of , B spectrin has been described, presumably leading to an unstable protein and subsequent spectrin This 0 spectrin mutation also resulted in the defective binding of spectrin to protein 4.1. We have also previously reported, in a preliminary form, a truncated 0 spectrin due to a large genomic deletion resulting in an in-frame skipping of exons 23 and 24. 
MATERIALS AND METHODS

Prltient
The family under study consists of three members: The patient was incidentally found to be mildly anemic at age 4 although no diagnosis was reached at that time. At age S. he presented with marked fatigue following an episode of streptococcal pharyngitis and was found to have a hemoglobin of 8 g/dL. After recovery from this acute event. his hemoglobin stabilized between 10 and I I g/dL, with a reticulocyte count around 7. an MCV of 80. and an undetectable haptoglobin. His peripheral blood smear showed marked spherocytosis with some spiculated spherocytes (Fig I ) and the red cell osmotic fragility was markedly increased. No splenomegaly was found by physical examination. Thc parents ofthc patient are asymptomatic and present no detectable hematologic abnormalities.
Anrrlwis of the Erythrocyte Mc~mhrcrne Protei11
These methods have been described previously and include (1) erythrocytc membrane preparation".": (2) analysis of the erythrocyte mcmbrane proteins by SDS-PAGE ( 3 5 % to I 7 9 gradient Fairbanks gels and 1 0 % Laemmli polyacrylamide gels)": ( 3 ) immunoblotting using polyclonal antibodies raised against a spectrin. B spectrin. and ankyrin": and (4) spectrin extraction at 4°C" and relative determination of spectrin dimers (SpD) and spectrin tetramers (SpT) by nondenaturing gel electrophoresis."'
PCU Amplifcntion of Reticulocyte Spectrin cDNA
Total RNA isolated from re~iculocytes~~ was reverse transcribed using random primers. Overlapping segments of the B spectrin cDNA were amplified by the polymerase chain reaction (PCR). The segment encompassing exons 16 
Southern Rlot Anrclvsis of Genomic DNA
Ten micrograms of genomic DNA isolated from peripheral blood mononuclear cells:x were digested with two restriction enzymes independently ( X h I and EcoRI). The DNA fragments resulting from this digestion were fractionated on a 0.7% agarose gel, transferred to a nylon membrane (Zetaprobe. Bio-Rad Laboratories, Richmond. CA) by nonalkaline Southern blotting. Probes were labeled with "P dATP by random priming (Megaprime DNA labeling system. Amersham. UK) and hybridized to the nylon membrane as described."'
PCU Anlplifccrtion of Intron-Exon Roundnries
Genomic DNA was isolated from peripheral blood leukocytes as described previously.'x Amplification of introns IS, 16. and 17 was carried out in order to amplify the donor and acceptor splice sites flanking exons 16 and 17. For the small introns I6 and 17, the amplifications were performed in a SO-pL reaction mixture containing SO mmol/L KCI, I O mmol/L Tris-HCI, 2 mmol/L MgCI2, 0 . I % gelatin, and I O 0 pmol of each primer. The primers used were sense primer 304 with antisense primer BS44 for intron 16. and sense primer BS 43 with antisense primer BS42 for intron 17. A 40 cycle amplification was carried out, each cycle consisting of I minute at 95°C. I minute at 50°C. and 3 minutes at 72°C. For intron IS, which exceeds 4 kb, the amplification was performed using the conditions described previously for amplification of large DNA fragments'" and using sense primer BSI with antisense primer 35 I . All primers used to amplify individual introns are designed within the adjacent coding exon sequences.
Direct Sequencing of Amplified DNA
DNA fragments generated by PCR amplification were purified using the geneclean system (B10 101. Natick. MA) and sequenced using the Sequenase kit, version 2.0 (USB, Amersham, Cleveland, OH) as recommended by the manufacturer with the following minor modification: the initial alkaline denaturation of the template is replaced by simple heat denaturation in presence of the sequencing primer (95°C for S minutes). followed by quick chilling on ice for
I O minutes.
Subcloning and Sequencing of Amplijed DNA DNA fragments generated by PCR amplification were purified using the geneclean system (B10 101) and subcloned into the pCRIl cloning vector (Invitrogen Corp. San Diego, CA). After transformation in competent Escherichin coli cells. the recombinant DNA clones were sequenced by the dideoxynucleotide sequencing method of Sanger, Nicklen, and Coulson:"
For personal use only. on October 23, 2017. by guest www.bloodjournal.org From cDNA Quantitation by PCR mRNA was prepared from peripheral blood reticulocytes and reverse transcribed to cDNA using random primers. To quantify the relative amounts of the normal and abnormal transcripts, we amplified by PCR a cDNA segment overlapping the truncated fragment using primers BSI and BS42 located on exons 15 and 18, respectively. This amplification resulted in a 1,100 bp DNA fragment from the normal allele, and a 140 bp fragment from the truncated allele. A 500-pL reaction mixture containing 50 mmol/L KCI, 10 mmol/L Tris-HC1,2 mmol/L MgCI, , 0.1 % gelatin, 100 pmol of each primer, 0.2 mmoVL radioactive dATP, 0.2 mmol/L of the other dNTP, and 2 U of Taq polymerase, was aliquoted in 15 PCR tubes. A 30 cycle PCR amplification was initiated, each cycle consisting of 1 minute at 95°C. 1 minute at 55"C, and 2 minutes at 72°C. The tubes were removed successively at the end of each cycle between cycle 15 and cycle 30. The DNA fragments resulting from this amplification were fractionated on a 5% polyacrylamide gel, for 10 hours, at 180V and their amount quantified by exposure of the gel to autoradiography followed by densitometric analysis of the film. Also, After localization by autoradiography, the bands were cut off the gel and the radioactive signal quantified by beta spectrometer. The relative abundance of the truncated band to the normal band was determined for each one of the 15 samples.
In Vitro Assay of Spectrin Synthesis, Stability, and Incorporation Into the Membrane
The methods used for this assay have been extensively described elsewhere!2 Briefly, they include (1) a two-phase liquid culture system for the maturation of erythroid progenitors using the system described by Fibach et a14' ; and (2) pulse label and pulse chase experiments of late erythroblasts isolated from liquid culture.
Two-phase liquid culture system for the maturation of erythroid progenitors. Peripheral blood was obtained from healthy donors and patients, and mononuclear cells were separated by Ficoll-Hypaque (Pharmacia Fine Chemicals, Piscataway, NJ) gradient density centrifugation. The mononuclear cells were collected and cultured in a two-phase liquid culture system as described earlier.4' Briefly, in the first phase, mononuclear cells ( I06/mL) were cultured in alpha minimum essential medium (MEM) (GIBCO, Grand Island, NY) supplemented with 10% fetal calf serum (FCS) (Hyclone, Logan, UT) and 10% conditioned medium collected from cultures of the 5637 bladder carcinoma cell line. After a l-week incubation at 37°C in an atmosphere of 5% CO2, the nonadherent, nonphagocytic cells were harvested and cultured in the second phase in alpha medium containing 30% FCS, 1% deionized BSA, IO-' mom 2-mercaptoethanol, 1.5 mmol/L glutamine, moVL dexamethasone, cyclosporine A, and 1 U/mL human recombinant erythropoietin (generously provided by Ortho-Biotec, Raritan, NJ). After 4 days in the second phase, lymphocytes were removed using a 2 mL cushion of 45% Percoll. The remaining cells containing predominantly proerythroblasts were resuspended in the second phase culture medium, and incubation continued at 37°C in a humidified atmosphere containing 5% O2 and 5% CO,. On day 12 or 13 of the second phase, when at least 90% of the cells were benzidine positive and appeared to be at the late erythroblast (orthochromatophilic normoblast) stage by Wright-Giemsa staining, the cells were harvested and used in the present study.
Pulse labeling of cells with ["Slmethionine. Late erythroblasts isolated from liquid cultures were washed twice in MEM without methionine and resuspended in 10 mL of the same medium containing 10% FCS p r e w m e d to 37°C. The cells were then metabolically labeled with [''Slmethionine (30 pCi/mL, 1, OOO Ci/mmol; ICN Biomedicals, Irvine, CA) for different lengths of time. For the pulsechase experiments, further incorporation of [35S]methionine was stopped by the addition of 0.4 mmoliL unlabeled methionine and the incubation was then continued for &fferent time periods (0-120 minutes). At the end of the labeling period, 10 volumes of 155 mmoVL choline chloride and 5 mmol/L HEPES, pH 7.1, were added and the cells were harvested by centrifugation. These cells were treated with diisopropyl fluorophosphate (Sigma Chemical CO, St Louis, MO), lysed in 4 volumes of a buffer containing Triton X-100 (150 mmol/L NaCI, 10 mmoVL Tris-HCI, pH 7.2, S mmol/L MgCI2, 2 mmoVL EDTA, 0.25 mmoVL dithiothreitol, 1 mmol/L phenylmethyl sulphonyl fluoride, 1 mmol/L leupeptin, 10 pg/mL aprotinin, and 1% Triton X-IOO), and separated into soluble and insoluble fractions, as described earlie?' to measure rates of synthesis and assembly into the membrane skeleton, respectively. Spectrin was immunoprecipitated from these fractions using affinity-purified antispectrin antibodies by the method described previously."
RESULTS
Biochemical Characterization of the Mutant p Spectrin
An additional band migrating between band 2.1 and 2.2, with an estimated molecular weight of 190 kD was revealed by 3.5% to 17% gradient SDS-PAGE analysis of the patient's red cell membrane proteins. (Fig 2A) . This band could also be visualized on 10% Laemmli gel (data not shown).
The extra band reacted with a p spectrin polyclonal antibody, when analyzed by Western blotting (Fig 2B) . This truncated protein constituted approximately 12% of the total p spectrin present on the membrane. Using densitometric analysis of SDS-PAGE gels, the spectrin to band 3 ratio (including the truncated protein) was 0.84 (Normal: 0.97 ? 0.10) indicative of an overall moderate spectrin deficiency on the membrane. Nondenaturing gel electrophoresis of spectrin extracts performed at 4°C showed a normal spectrin dimers to tetramers ratio, suggesting that the deleted portion of , B spectrin does not affect the spectrin heterodimer contact site (data not shown). The red cells of both parents had no detectable membrane abnormality as assessed by these methods.
Characterization of the Molecular Defect Underlying the
Truncated p Spectrin
PCR amplification of overlapping cDNA fragments spanning the entire , B spectrin cDNA was carried out. Amplification of the sequence derived from exons 15 to 18, was carried out using sense primer BS1 with antisense primer BS42, and revealed two size DNA products in the patient (Fig 3A) , one of expected size (1,100 bp) and a truncated fragment (140 bp). This finding was confirmed using a second set of primers (sense primers 339 with antisense primer BS42 shown in Fig 3A) to amplify the sequence spanning exon 14 to 18. Sequencing of the truncated 140 bp abnormal PCR product revealed a 960 bp in-frame deletion of the sequence normally contributed by exons 16 and 17 ( Fig 3B) . These exons encode the C-terminal part of repeated segment 6, the entire repeated segments 7 and 8, as well as most of repeated segment 9 (Fig 3C) .
In order to elucidate the underlying molecular defect, we first focused our efforts on detecting a large genomic deletion as it appeared to be the most likely event that would be responsible for more than one exon skipping. Genomic DNA, prepared from the three family members, was analyzed by Southern blot hybridization using two restriction enzymes independently (EcoRI and Xba I), and a cDNA (Fig 4) . we amplified by PCR introns IS. 16, and genomic deletion was unlikely to be the underlying molecu- mutations were detected at any other intron-exon boundaries. Likewise, no mutations were found when exons 16 and 17 were amplified by PCR and sequenced (data not shown). Sequencing of the donnor splice site of intron 17 using genomic DNA from both parents did not show the same mutation. suggesting a de novo mutation in the proband (data not shown).
Moleclrlor Brrsis j?w r l w Specrrin I)qficierlc:\.
To understand the mechanism underlying the imbalance hetween the amounts of the normal and the truncated p spectrin present on the membrane, we have examined the stability of the transcriptional message. as well as the synthesis and stability of the truncated protein.
We first investigated the stability of the mRNA by relative quantitation of cDNA as described in the Methods section (Fig S) . The PCR amplitication of the patient's cDNA. using primers BSI and BS42 Ranking the deleted segment, yields two fragments, one of 1 .l00 bp corresponding to the normal allele and a 140 bp fragment corresponding to the mutant allele. The relative amount of these two products was examined after each PCR cycle between cycles 20 and 30 as described in the Methods section. Despite the smaller size of the mutant band (which one would therefore expect to be preferentially amplified). we find that the ratio of the truncated to the normal band remains low at 0.34 -t 0.08. This result suggests that the mRNA generated by the transcription of the mutant p spectrin gene is less abundant than its normal counterpart in the cytoplasm of reticulocytes and may therefore be unstable.
We next examined the synthesis and stability of the newly synthesized p spectrin using an in vitro liquid culture system allowing the isolation of late erythroblasts from peripheral blood burst-forming unit-erythroids (BFU-Es) Pulse label and chase experiments described in the Methods section reveal that the truncated p spectrin can be immunoprecipitated from the erythroblast cytosolic fraction (Fig 6) . However. after 90 minutes of labeling (ie. at time O), it is much less abundant then the normal protein and represents only a small fraction of the total p spectrin in the cytoplasm. This result is in agreement with the finding of a decreased amount of the mutant mRNA in reticulocytes. Furthermore, the presence in the patient's sample of several degradation products of p spectrin (absent in control samples) suggests an increased susceptibility to proteolytic degradation of the truncated protein. The expected high ratio of a spectrin to p spectrin which reflects the excessive synthesis of a ~pectrin.".'~ is further increased in the patient compared with the control (Fig 6) . confirming the overall deficiency in normal p spectrin in the cytoplasm of the patient's erythroblasts. We can conclude from these experiments that the decrease in the spectrin incorporation into the membrane is probably the consequence of the concerted occurrence of an unstable transcriptional message and an increased susceptibility to proteolytic degradation of the mutant protein.
DISCUSSION
Several mutations of the red cell skeletal proteins have been described in association with hereditary spherocytosis. However, within the subset of patients with isolated spectrin deficiency. a single report describing a point mutation of a conserved aminoacid of the p spcctrin gcne has been published.7' Based on bacterial expression of spectrin peptides, it was presumed that the spectrin deficiency was the conse- quence of an increased protein degradation in vivo, as mutant peptides were unstable and highly susceptible to oxidative injury and proteolytic degradation. We have also previously reported. in a preliminary form, a truncated p spectrin mutant lacking exons 23 and 24 (corresponding to most of repeated segments 12 and the first helix of repeated segment 13) associated with an HS phenotype.3' We were able to show that despite normal synthesis and stability of the protein in the cytoplasm of erythroblasts, the mutant protein was not incorporated into the membrane skeleton. We postulated that conformational changes of the protein affecting the nearby ankyrin binding domain or, less likely, the heterodimer nucleation site was responsible for the decrease in the skeletal incorporation of the defective spectrin. In this report we describe another truncated protein associated with an HS phenotype and show that it constitutes only 12% of the total spectrin on the membrane. We show that the deletion of exons 16 and 17 corresponding to the C-terminal end of repeated segment 6, the entire repeated segments 7 and 8, as well as most of repeated segment 9, is due to a single point mutation at position + 1 (G + A) of the donor consensus splice site of intron 17 leading to an aberrantly spliced p spectrin transcriptional message. This mutation has occurred de novo as it is absent in both parents. Unlike spectrin Durham, the resulting mRNA appears to be unstable. Furthermore, the pulse chase studies of newly synthesized spectrin provide evidence that the mutant protein may also be highly susceptible to proteolytic degradation.
Previous studies have revealed that the LY and p subunits of spectrin, like other subunits of multimeric complexes are synthesized in excess of the amounts assembled on the membrane.JJ,J5 and that excess unassembled subunits, unlike their membrane bound counterparts, are rapidly degraded in the cytoplasm. However, the amount of (Y spectrin synthesized exceeds by several-fold the amount assembled on the membrane, and by threefold the amount of p subunit syntheFurthermore, the two subunits of spectrin are degraded by two distinct intracellular pathways: while (Y spectrin is degraded slowly by a lysosomal-type pathway, with a half-life of 2 hours, the unassembled p subunit is degraded much faster by a soluble cytoplasmic factor with a half-life of about 15 minutes." These observations suggested that the extent of assembly of newly synthesized subunits may be regulated at the posttranscriptional level. Although availability of and accessibility to the ultimate stabilizing membrane receptor may play an important role in this regulation, it is also believed that selective proteolysis of key components may provide a means of control of multimeric subunit a~s e m b l y . *~~~~ More specifically, in the case of spectrin, the limiting factor for its assembly on the membrane, may be the rate of turnover of its most unstable component, the p subunit. This is supported by the fact that the rate of degradation of 0 spectrin closely matches its rate of synthesis and rate of assembly on the membrane.'" This model would readily accommodate the hypothesis proposed in this report, which attributes the spectrin deficiency to a decreased incorporation of the mutant spectrin into the membrane, resulting from a marked shortage in p spectrin. the limiting factor of spectrin assembly.
Although we cannot exclude the possibility that another mutation in conjunction with the one described here may contribute to the phenotype, the previous finding of cosegregation of the HS phenotype with a mutant p spectrin supports the concept that a defect in spectrin could be manifest in the heterozygous state.." It is worth noting that in the mouse model of 0 spectrin mutant (the jaundiced mouse j d jn), the homozygous state of the mutation results in a severe hemolytic anemia while the heterozygous mouse, which has
For personal use only. on October 23, 2017. by guest www.bloodjournal.org From a 50% decrease in p spectrin synthesis, would appear normal.49 Several hypotheses could be proposed to reconcile this mouse model with the one described here: it is not unlikely that the heterozygous mouse has a mild, compensated hemolytic picture with no clinical significance as is the case with our patient. Alternatively, the presence of the truncated protein on the membrane may have some other deleterious effect that is not clearly understood.
It is interesting to note that this truncated protein is the result of the simultaneous deletion of exons 1 6 and 17, due to a single point mutation at position + 1 of the donor consensus splice site of intron 17. A recent survey of mammalian mutations available in the Genbank database identified over 100 fully characterized splice site mutations associated with defective genes.'" These were classified in four types: exon skipping, activation of a cryptic splice site, creation of a pseudo-exon within an intron, and intron retention. The first pattern, exon skipping, is the most frequently encountered (5 1 %), and mutations of the donor splice site are more common than those of the acceptor splice site. Among these, there is no single description of mutation of the donnor splice site resulting in the deletion of the involved exon as well as the further upstream exon as reported here in the case of spectrin Winston-Salem. However, mutations in which the further downstream exon is also skipped have been described by others."' This double exon skipping phenomenon supports the concept that parameters other than the splice site sequences play a significant role in the exon definition model. This model invokes pairing between the splice sites across an exon, as opposed to pairing across an intron. In this exon definition model, the pre-mRNA is scanned by the splicing machinery searching for a pair of closely spaced splice sites." However, it appears that, aside from the appropriate splice sequences, other constraints are imposed: a minimum as well as a maximum size seem to be necessary for the exon definition. Only 3.5% of exons are longer than 300 nucleotides, and only 1% are longer than 400 nucleotides. Furthermore, It is also clear from the observations gathered on the differential recognition of exons (alternative splicing), as well as mutually exclusive exons, that factors other than splice site sequences may be cru~ial.~' Steric hindrance, secondary structures of the mRNA, and enhancer sequences, among other mechanisms have been proposed as plausible explanations. The double exon skipping observed in spectrin Winston-Salem, lends credence to the exon definition model and its observed constraints. Despite having a high scoring splice signaling,'' the size of exon 1 6 (757 nucleotides) is unsuitably large, a common finding in alternatively spliced exons.s2 We propose that the double exon skipping described in spectrin Winston-Salem represents an example of mutually inclusive exons, in which the definition of exon 16, due to its unusually large size, is contingent to the recognition of exon 17 by the splicing mechanism. This may occur by means of specific secondary structure of the mRNA, or other poorly understood mechanisms.
It should finally be pointed out that the phenotype presented by the patient is very similar to the one described in spectrin Durham,32 consisting of a mild to moderate hemolytic anemia, associated with a significant spherocytosis and frequent spiculated red cells on the peripheral blood smear.
Acanthocytes were also reported in spectrin Kissimmee." The significance of this observation remains, at this point, uncertain, however, the presence of acanthocytes may be a feature of p spectrin mutations in HS.
In summary, we have described a new truncated 0 spectrin mutant, caused by a point mutation involving the donor splice site of intron 17, and resulting in a double exon skipping. We have provided evidence that the instability of the transcriptional message and the susceptibility of the truncated spectrin to proteolytic degradation concertedly lead to the scarcity of the aberrant protein and ultimately to spectrin deficiency on the membrane. This mutant spectrin underscores the importance of the regulating role played by the / 3 spectrin molecule in the assembly of the c y @ spectrin heterodimers on the membrane. For personal use only. on October 23, 2017. by guest www.bloodjournal.org From
